We show that EGFL7, so far considered an endothelial-specific molecule, is abnormally expressed and regulated in normal and SSc FBs, and may influence the angiogenic process by modulating the expression of COL1A1 thus modifying the ECM. Here, EGFL7 is linked to systemic sclerosis.